Smoking cessation among people with severe mental illness: a study on effectiveness and implementatio
- Conditions
- AddictionSevere Mental IllnessSmoking Cessation10039628
- Registration Number
- NL-OMON54435
- Lead Sponsor
- Vrije Universiteit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 318
- Above 18 years old
- Smoker (>= 5 cigarettes) and wish to quit smoking
- Documented diagnosis of schizophrenia, other psychotic disorder and/or
disorders defined as severe mental illness according to Delespaul
consensusgroup at Maastricht University
- Dutch language skills
- Contra-indications (determined by a psychiatrist/physician) for participation
due to acute psychiatric crisis or somatic disease
- Pregnancy or breastfeeding in women at the time of inclusion
- Primary alcohol or other substance use disorder, with exception of cannabis
use disorder
- Lacking capacity to consent, to complete questionnaires, or participate in
peer support group session
- Non-Dutch speaking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameter is smoking cessation after 12 months. This outcome<br /><br>will be validated by measuring the exhaled carbon monoxide (CO) level with a CO<br /><br>monitor. The measurement of CO level provides an immediate, non-invasive method<br /><br>of assessing smoking status. We defined smoking cessation as a CO reading less<br /><br>than 10 ppm. Additional smoking cessation parameters are the number of<br /><br>cigarettes smoked (reported by the patient) and scores on the Fagerström Test<br /><br>for Nicotine Dependence (FTND). </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study parameters are physical health (physical fitness (6 minute walk<br /><br>test) and cardiovascular risk (i.e. blood pressure, lipid profile and glucose<br /><br>metabolism); mental health, including psychiatric symptoms (depression, anxiety<br /><br>and psychotic symptoms) and use of psychopharmaca, quality of life and<br /><br>self-efficacy. Finally, we will calculate BMI to assess weight change after the<br /><br>start of the smoking cessation intervention.</p><br>